GSK-3335065

N/A

Report date: 2022/07/19 20:00:45
NME

Base Information

Drug NameGSK-3335065
Drug Alias NameGSK-3335065
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionKynurenine inhibitors
TargetsKynurenine
Therapy Area/IndicationsPancreatitis, Acute Necrotizing
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited Kingdom
CombinationsNo
Global Highest StatusDiscontinued (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesGlaxosmithkline Plc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesGlaxosmithkline Plc
Active IndicationsN/A
Inactive IndicationsPancreatitis, Acute Necrotizing

Other Information

ATC CodeN/A
Related LinksN/A